Akros
EventsASHUBIO

Catalyst event

Johnson & Johnson (JNJ)

From Akros SCHK HK-U.S. Biotech Index (ASHUBIO)

Johnson & Johnson received FDA De Novo authorization for the OTTAVA robotic surgical system in the United States.

Korean translation

Johnson & Johnson이 미국에서 OTTAVA 수술 로봇 시스템의 FDA De Novo 허가를 획득함.